Lois Gibson

Title: Lois Gibson: Innovator in Drug Formulation

Introduction

Lois Gibson is a prominent inventor based in Bradley Beach, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, her work focuses on improving the efficacy and delivery of medications.

Latest Patents

Gibson's latest patents include a sustained release formulation of methotrexate, which serves as both a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent. This formulation comprises a multivesicular liposome and methotrexate (MTX), allowing for a controlled release of the drug. The administration of this formulation results in a concentration of MTX between 5% and 50% of that found in an immediate release dosage form, with effects lasting from about 1 to 30 days. Additionally, her patents disclose methods for treating autoimmune diseases and cancer through these innovative formulations.

Career Highlights

Lois Gibson is currently associated with Pacira Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its potential to improve patient outcomes in the treatment of various diseases.

Collaborations

Gibson collaborates with notable colleagues, including Liangjin Zhu and Benjamin W. Li, contributing to a dynamic research environment that fosters innovation.

Conclusion

Lois Gibson's contributions to drug formulation exemplify the impact of innovative thinking in the pharmaceutical industry. Her patents reflect a commitment to enhancing treatment options for patients, showcasing the importance of research and collaboration in advancing medical science.